Key result
Apo E-D phenotype strongly linked to beta-VLDL presence, occurring in ~100% vs under 1% in Apo E-N.
Observational
Answers are grounded in this paper and cite their sources.
The two autosomal codominant alleles of the Apo E-N/D polymorphism, Apo En and Apo Ed, have a considerable influence on plasma lipid levels and distribution in man. Serum cholesterol levels are highest in phenotype Apo E-N, intermediate in phenotype Apo E-ND, and low in phenotype Apo E-D. Contrary VLDL-cholesterol is highest in phenotype Apo E-D, intermediate in heterozygotes, and lowest in phenotype Apo E-N. Serum-triglyceride, VLDL-triglyceride and the ratio of VLDL-cholesterol/serum-triglyceride are also intermediate in phenotype Apo E-ND between the two opposite homozygous groups. 10% of heterozygous Apo E-ND subjects exhibited a beta-VLDL subfraction compared to 0.8% in phenotype Apo E-N and 100% in Apo E-D. Hence the three phenotypic groups exhibit metabolic differences in vivo, and the gene Apo Ed has a mild dyslipoproteinemic effect even in a single dose. The Apo E-N/D polymorphism may therefore be a major influence on the occurrence of arteriosclerotic vascular disease in man.
No takes yet. Share an insight, caveat, or question.
Utermann et al. (1979) reported an observational. Apo E-N/D polymorphism vs. Apo E-N phenotype was evaluated on Presence of a beta-VLDL subfraction. The Apo E-N/D polymorphism influenced plasma lipid profiles, with a beta-VLDL subfraction present in 100% of Apo E-D, 10% of Apo E-ND, and 0.8% of Apo E-N phenotypes.
Synapse has enriched 10 related papers. Consider them for comparative context: